Recall: D-1435-2019

Class II - Potentially Harmful

Class IIClassification

2019-06-13Initiated

TerminatedStatus

Baxter Healthcare CorporationFirm

Product

Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64

Reason

Failed Stability Specifications

Distribution

Nationwide within the United States

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.